Related Experiment Videos
Lung function in beta-thalassemia patients: a longitudinal study.
G Piatti1, L Allegra, V Fasano
1Istituto di Tisiologia e delle Malattie dell'Apparato Respiratorio, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Fondazione IRCCS, Milano, Italia. gioia.piatti@unimi.it
Acta Haematologica
|July 1, 2006
Summary
Pulmonary function tests (PFTs) in beta-thalassemia patients show abnormalities, but lung function remains stable over time. Optimal iron balance through chelation therapy may improve PFT results.
Area of Science:
- Pulmonary Medicine
- Hematology
- Genetics
Background:
- Beta-thalassemia is associated with pulmonary function abnormalities.
- The long-term pulmonary function changes in beta-thalassemia patients are not well understood.
Purpose of the Study:
- To investigate the longitudinal changes in pulmonary function tests (PFTs) in asymptomatic beta-thalassemia patients.
- To identify predictors of PFT abnormalities in this population.
Main Methods:
- A longitudinal study involving 18 beta-thalassemia major and 11 beta-thalassemia intermedia patients.
- Pulmonary function tests (including spirometry, body plethysmography, and DL(CO)) were conducted in 1996 and 2003.
- Echocardiography was used to rule out pulmonary hypertension.
Main Results:
- In 1996, 55.5% of major and 45.4% of intermediate beta-thalassemia patients had restrictive PFT patterns.
- By 2003, the prevalence decreased to 38.8% and 27.2%, respectively.
- Carbon monoxide diffusion capacity (DL(CO)) remained stable, reduced in some major but normal in intermediate patients.
Conclusions:
- Asymptomatic beta-thalassemia patients exhibit a high prevalence of PFT abnormalities, which do not significantly worsen over time.
- Improved PFT outcomes may be linked to effective iron chelation therapy and maintaining iron balance.